Breakthrough in the production of large-scale artificial blood

For the first time in the UK, scientists have successfully developed red blood cells from embryos of artificial implants, a promising breakthrough that can produce artificial blood on a large scale.

Illustration.Source: Internet

Scientists used more than 100 samples of embryos taken from maternity hospitals, divided into different lines to synthesize red blood cells. One of these lines, called RC-7, has resulted in the conversion of embryonic stem cells into blood cells and continues to turn into red blood cells containing hemoglobin - the pigment blood that carries oxygen in the blood.

From these red blood cells, scientists will develop into blood type O, a blood group that can be transmitted to all patients without rejection, but very rarely, because only about 7% World Population.

Experts say an artificial blood production project could promise a revolution for the health sector, because it provides a stable supply of blood, ending its dependence on voluntary donations of blood.

Artificial blood also ensures 'cleanness' - that is, not affected by the types of donor pathogens.

One of the main requirements of artificial blood is that it must be cheaper than donated blood. According to calculations, one liter of donated blood, if including test costs and other costs, can take up to 1,000 pounds to be able to pass on to patients.

If successful, the project could produce more than 1 million liters of blood per year. However, artificial blood samples must also be approved by competent authorities before being tested in humans.

This process is expected to take about five years.